Olinciguat

N/A

Report date: 2025/07/22 20:00:10
NME

Base Information

Drug NameOlinciguat
Drug Alias NamesGC stimulator - IronwoodIW-1701
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSoluble guanylate cyclase stimulants
TargetsSoluble guanylate cyclase
Therapy Area/IndicationsAnemia, Sickle CellEsophageal Achalasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited KingdomLebanon
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIronwood Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsAnemia, Sickle CellEsophageal Achalasia

Other Information

ATC CodeN/A
Related LinksN/A